Thanks to the Almighty for @ESEndocrinology Early Investigator Award 🙏🏽🙏🏽🙏🏽

RT @EJEndo: Severe Symptomatic #Hyponatraemia in Europe: Insights into Current Clinical Practice by Julia Beck , Muhammad Fahad Arshad , Ah….

@ChristCrain @Julia1Beck @Ahmed742Iqbal.

🎉 Delighted to share our latest paper in @EJEndo evaluating clinical practice and perspectives of Endocrinologists from 36 🇪🇺 countries. 📌 This highlights the need for future research & evidence-based review of the @ESEndocrinology guidelines. Link:

Pleased to share our real world study which shows that insulin pumps ⬇️ all-cause mortality & DKA risk compared to multiple daily injections. Read full open access article here: @Ahmed742Iqbal @Simon_Berry_.

Thanks @ESEndocrinology for the honour!.

Still time to check out our poster P128 at the @ESEndocrinology @EuroSPE meeting. First study in children & adults to confirm morning cortisol cut offs (with two different modern immunoassays) that can be utilised in clinical practice to wean patients from glucocorticoids

RT @hormone_doc: Enjoyed seeing these data confirming utility of 9am cortisol to confirm adrenal insufficiency and to exclude adrenal insuf….

Check out P25 for results of the largest European survey on Severe Hyponatraemia, joint venture between @UniBasel_en @sheffielduni at ESPE/ECE meeting. Key results:. 1) Significant variation in practice.2) Most clinicians prefer cautious approach.3) ESE guidelines need an update

Thanks to @AscendisPharma for inviting to their headquarters here in Copenhagen. Great insights into the TransCon technology shared with us. This looks quite promising with potential to improve patient care in several endocrine conditions, especially HypoPT

@ESEndocrinology @EuroSPE @ChristCrain @Ahmed742Iqbal @Julia1Beck @ClinNeuroEndo.

Proud to have our poster shortlisted for Top 30 posters at @ESEndocrinology @EuroSPE #ESPE_ECE2025. @ChristCrain @Ahmed742Iqbal @Julia1Beck

Presented our Post-surgical Hypopara study outcomes today at Bone and Calcium session at the @Soc_Endo #BES2025 .#Harrogate. @ParathyroidUK

RT @Ahmed742Iqbal: @DrFahadArshad @MGoonoo @Simon_Berry_ @drpratikc @AliaGilani @WilmotEmma.

RT @EndoConnect: Recently published research recommends that desmopressin should be listed as a critical drug and education packages should….

@ChristCrain @AtilaCino @Julia1Beck.@Ahmed742Iqbal @MGoonoo @saneshks @MiguelDeBono2 @PituitarySoc @PituitaryWNews @pituitaryorg @pituitaryconne1 @ESEndocrinology @ENEA_Young @EYEScientists @mileslevyendo @endocrine @sheffielduni @ShefUni_ClinMed.

Sharing our latest @EndoConnect paper from @SheffieldHosp showing that in-hospital desmopressin omissions/delays in AVP-D patients are not uncommon & awareness of the condition among non-endocrine HCPs is below-average.@Pituitary_org @Soc_Endo.

RT @ESEndocrinology: It's the final day of EuroPit 2024 in #Annecy - a great few days of learning, collaborating and networking with our co….

Three days dedicated to pituitary disorders with so many amazing talks and discussions.#Europit is a must for all those passionate and eager to learn more.@ESEndocrinology

Thanks you @ESEndocrinology for the invite 🙏🏽.